How long is the survival rate of endometrial cancer? With early treatment, the five-year survival rate can be as high as about 90%

The survival period of endometrial cancer is related to the histological classification, the patient's age, whether lymph node metastasis occurs, and the degree of malignancy of the disease. Generally, for patients with type I endometrial cancer, if they are treated early, the five-year survival rate can be as high as about 90%. For patients with type II, once metastasis occurs and the prognosis is poor, the five-year survival rate may be as low as about 40%.

Endometrial cancer is divided into four stages according to pathological development. Stage I has the highest treatment success rate and survival rate, while stages II, III, and IV may have a direct impact on prognosis and survival rate due to disease progression and accompanying complications. Therefore, the survival rate of endometrial cancer depends on the specific situation. So what is the survival rate of endometrial cancer at different stages?
1. What is the survival rate of endometrial cancer ? For patients with early-stage endometrial cancer, the five-year survival rate can reach about 60%-90% after timely hysterectomy. Postoperative chemotherapy and Chinese medicine treatment can prevent cancer cell metastasis and recurrence. If endometrial cancer develops to the middle and late stages, about 70% of patients can have their symptoms alleviated after chemotherapy, and their five-year survival rate can reach about 40%-50%. However, the specific survival rate needs to be combined with age, treatment method, histological type and the presence or absence of metastasis.
Factors that affect the survival rate of endometrial cancer
1. Age factor <br/>The survival rate of this disease is directly related to the age of onset. The older the age of onset, the worse the prognosis and the lower the survival rate. Generally, for women under the age of 50, the overall survival rate can exceed 90% after active treatment for five years. However, for elderly patients over the age of 70, the survival period of more than five years is less than 75%. This is mainly because older patients have fewer underlying diseases, better tolerance to treatment, and the clinical stage is usually earlier, making treatment less difficult.
2. Histological type <br/>Clinically, endometrial cancer is mainly divided into type I endometrial adenocarcinoma and type II non-endometrial adenocarcinoma according to the characteristics of the disease. Among them, most type I patients are young, well differentiated, and less malignant, so the survival rate is higher. Type II patients, on the other hand, have poor differentiation and a higher possibility of metastasis, so the survival rate is lower.
3. Lymph node metastasis <br/>Endometrial cancer is prone to metastasis in the later stages, mostly to lymph node metastasis, and whether metastasis occurs directly affects the prognosis of the disease. Generally, the five-year overall survival rate of patients without lymph node metastasis is over 90%; for those with metastasis, the survival rate drops to 60%. Especially for patients with stage I endometrial cancer, even if the stage is early, if metastasis occurs, lymphedema and lymph retention cysts are likely to occur after lymph node removal, which will directly affect the quality of life of the patient.